Medtronic commissioned Yale University researchers to conduct independent studies of its Infuse bone graft products, allegedly in response to a report by an industry journal charging that the company had failed to reveal that the products could cause potentially critical complications.
http://www.prweb.com/releases/medtronic_yale_study/05/prweb10786396.htm
http://www.prweb.com/releases/medtronic_yale_study/05/prweb10786396.htm
No comments:
Post a Comment